SAM #75N98026Q00422

NIH Maintenance Services for Illumina MiSeq and NextSeq Sequencing Machines

NIH is seeking maintenance services for Illumina MiSeq and NextSeq sequencing machines to support ongoing cancer research at its Bethesda facility. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Logistics and Operations (OLAO), Office of Acquisition and Logistics Management (OALM), Hospital and Laboratory Support Division - OEM Highlight: - Illumina is the Original Equipment Manufacturer (OEM) for MiSeq and NextSeq sequencing machines - Vendors: - Illumina (San Diego, CA) - Products/Services Requested: - Maintenance service contract for Illumina MiSeq and NextSeq sequencing machines - No specific part numbers or quantities provided - Unique/Notable Requirements: - Non-competitive procurement, intended to ensure uninterrupted genome-wide sequencing for cancer and epigenetic research - Supports Laboratory of Biochemistry and Molecular Biology (LBMB) - Place of Performance: - NIH federal facility in Bethesda, Maryland - Estimated contract value is not expected to exceed the simplified acquisition threshold ($350,000) - Period of performance aligns with annual maintenance, with responses due by the end of the current cycle

Description

Title:  :  Maintenance Service Contract for Illumina MiSeq and NextSeq  

 The Laboratory of Biochemistry and Molecular Biology (LBMB) carries out basic research into the mechanisms underlying cell growth, division, differentiation and homeostasis with a focus on the biology of chromosomes and the cell nucleus. LBMB fosters an interdisciplinary approach in which the methods of biophysics, biochemistry, genetics and cell biology are used in an interactive and collaborative research environment to solve problems of fundamental importance to cancer research. As part of this research, Next Generation Sequencing (high throughput genome-wide sequencing) is routinely performed to investigate questions relating to epigenetic regulation of the genome. The MiSeq and NextSeq machines are manufactured by Illumina and are used to obtain sequencing data for in depth genome-wide analy 

CLOSING STATEMENT 

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. 

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purpose of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.  

All responses must be received by May 31st , 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00422   Responses may be submitted electronically to Mr. Hanumanth Rao Vishnuvajjala  , Contracting Officer at vishnuh@mail.nih.gov. Fax responses will not be accepted. 

"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agenc

View original listing